238 related articles for article (PubMed ID: 32771630)
1. Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
Varisco TJ; Johnson ML; Thornton D
Int J Infect Dis; 2020 Oct; 99():373. PubMed ID: 32771630
[No Abstract] [Full Text] [Related]
2. Possible synergistic effects of hydroxychloroquine and steroids in COVID-19, time for a nuanced approach. Comment on Arshad et al.
Wiseman DM
Int J Infect Dis; 2020 Oct; 99():344-345. PubMed ID: 32768694
[No Abstract] [Full Text] [Related]
3. Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19".
Atkinson JG
Int J Infect Dis; 2020 Oct; 99():37. PubMed ID: 32738492
[No Abstract] [Full Text] [Related]
4. Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
Bonny A; Talle MA; Ngantcha M; Tayebjee MH
Travel Med Infect Dis; 2020; 37():101861. PubMed ID: 32889105
[No Abstract] [Full Text] [Related]
5. Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19.
Mazzitelli M; Davoli C; Scaglione V; Fusco P; La Gamba V; Matera G; Trecarichi EM; Torti C
Travel Med Infect Dis; 2020; 37():101826. PubMed ID: 32739472
[No Abstract] [Full Text] [Related]
6. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.
Arshad S; Kilgore P; Chaudhry ZS; Jacobsen G; Wang DD; Huitsing K; Brar I; Alangaden GJ; Ramesh MS; McKinnon JE; O'Neill W; Zervos M;
Int J Infect Dis; 2020 Aug; 97():396-403. PubMed ID: 32623082
[TBL] [Abstract][Full Text] [Related]
7. Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19.
Rosenberg ES; Holtgrave DR; Udo T
Int J Infect Dis; 2020 Oct; 99():38-39. PubMed ID: 32738483
[No Abstract] [Full Text] [Related]
8. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
Mégarbane B; Scherrmann JM
J Clin Pharmacol; 2020 Jul; 60(7):808-814. PubMed ID: 32434282
[No Abstract] [Full Text] [Related]
9. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.
Bessière F; Roccia H; Delinière A; Charrière R; Chevalier P; Argaud L; Cour M
JAMA Cardiol; 2020 Sep; 5(9):1067-1069. PubMed ID: 32936266
[TBL] [Abstract][Full Text] [Related]
10. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
[No Abstract] [Full Text] [Related]
11. An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19.
Intson K; Kumar S; Botta A; Neckles R; Leung C; Jawaid A
Swiss Med Wkly; 2020 Apr; 150():w20262. PubMed ID: 32347963
[No Abstract] [Full Text] [Related]
12. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
Lebeaux D; Revest M
Travel Med Infect Dis; 2020; 36():101819. PubMed ID: 32629139
[No Abstract] [Full Text] [Related]
13. Does Combining Severe and Mild Cases of COVID-19 Produce Low Fatality Rates After Treatment With Hydroxychloroquine and Azithromycin?
Fleury V
Am J Epidemiol; 2020 Nov; 189(11):1227-1229. PubMed ID: 32685969
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.
Okour M; Al-Kofahi M; Austin D
J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):187-188. PubMed ID: 32405664
[No Abstract] [Full Text] [Related]
15. Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949.
Rosendaal FR
Int J Antimicrob Agents; 2020 Jul; 56(1):106063. PubMed ID: 32674928
[No Abstract] [Full Text] [Related]
16. Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
d'Arminio Monforte A; Tavelli A; Bai F; Marchetti G; Cozzi-Lepri A
Int J Infect Dis; 2020 Oct; 99():75-76. PubMed ID: 32738491
[No Abstract] [Full Text] [Related]
17. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.
Kim AHJ; Sparks JA; Liew JW; Putman MS; Berenbaum F; Duarte-García A; Graef ER; Korsten P; Sattui SE; Sirotich E; Ugarte-Gil MF; Webb K; Grainger R;
Ann Intern Med; 2020 Jun; 172(12):819-821. PubMed ID: 32227189
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going.
Parra-Lara LG; Martínez-Arboleda JJ; Rosso F
J Glob Antimicrob Resist; 2020 Sep; 22():680-684. PubMed ID: 32622008
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine and azithromycin as a treatment of COVID-19.
Fanin A; Calegari J; Beverina A; Tiraboschi S;
Intern Emerg Med; 2020 Aug; 15(5):841-843. PubMed ID: 32474851
[No Abstract] [Full Text] [Related]
20. Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients.
Carlucci PM; Ahuja T; Petrilli C; Rajagopalan H; Jones S; Rahimian J
J Med Microbiol; 2020 Oct; 69(10):1228-1234. PubMed ID: 32930657
[No Abstract] [Full Text] [Related]
[Next] [New Search]